News Grower

Independent coverage of AI, startups, and technology.

Ars Technica May 5, 2026 at 19:32 Big Tech Stable Warm

RFK Jr. plans to curb antidepressants, which he falsely compares to heroin

Kennedy has made—and continues to make—many false claims about SSRIs.

Signal weather

Stable

The story has moved beyond the first headline and now acts as a reliable context anchor.

By Beth Mole Original source
RFK Jr. plans to curb antidepressants, which he falsely compares to heroin

In a brief appearance at a Make America Healthy Again Institute event Monday, anti-vaccine Health Secretary Robert F. Kennedy Jr. announced new federal initiatives to curb prescribing of antidepressants, which he has long attacked with false and dangerous claims. Mental health experts have previously condemned his rhetoric and are already pushing back on his new efforts. The MAHA event was focused on "overmedicalization," with participants broadly alleging—without evidence—that too many Americans, particularly youths, are overprescribed antidepressants in the class of selective serotonin reuptake inhibitors, or SSRIs. This class includes common medications such as Zoloft, Prozac, Paxil, and Lexapro, which are used to treat depression, anxiety, and post-traumatic stress disorder, among other conditions. Event participants focused on claims that the drugs are prescribed without informed consent, are harmful, and can be difficult to stop taking. False claims The topics closely echo Kennedy's claims. Among his many dangerous, evidence-free statements, he has suggested that too many people, including children, are put on SSRIs and that they make people violent. He has even suggested that they are the cause of mass shootings, including school shootings. In a podcast last year, he made the heinous claim that "every Black kid is now just standard put on Adderall, SSRIs, benzos, which are known to induce violence." His suggested solution is for black children to be "reparented" and work on farms. Read full article Comments

Stay on the signal

Follow RFK Jr. plans to curb antidepressants, which he falsely compares to heroin

Follow this story beyond a single article: new follow-ups, adjacent sources, and the evolving storyline.

We send a confirmation link first, then only meaningful digests.

Story map

Understand this topic fast

A quick entry into the story: why it matters now, who is involved, and where to go next for context.

Why it matters now

This story is still moving and pulling follow-up coverage.
There are already 6 connected articles in the same storyline to continue from here.
The story keeps orbiting around Antidepressants, Compares, and Continues, so the entity pages are the fastest way to build context.
Ars Technica already has 4 follow-up stories on the same theme.

Topic constellation

Open the live map for this story

See which entities, story threads, sources, and follow-up articles shape this story right now.

Click nodes to continue

Entity Cluster Article Hub Source

Story timeline

Continue with this story

A short sequence of events and follow-up stories to understand the arc quickly.

Jun 17, 2026 at 16:10 TechCrunch

PayPal Ventures shutters as company restructuring continues

The corporate venture arm ends after 10 years and 80 investments.

Jun 17, 2026 at 16:10 TechCrunch

PayPal Ventures shutters as company restructuring continues

The corporate venture arm ends after 10 years and 80 investments.

Jun 15, 2026 at 20:28 Hacker News

US battery manufacturing output continues to break records

Comments

Jun 12, 2026 at 16:19 Ars Technica

RFK Jr. melts down over NYT report, admits he blacklists reporters

NYT reported Kennedy is disengaged. Kennedy's response seems to show NYT is right.

Jun 12, 2026 at 11:15 Ars Technica

Pokémon Go players unwittingly contributed to tech with military drone uses

The repurposing of Pokémon Go data for AI training continues to draw scrutiny.

May 5, 2026 at 19:32 Ars Technica

RFK Jr. plans to curb antidepressants, which he falsely compares to heroin

Kennedy has made—and continues to make—many false claims about SSRIs.

How reliable this looks

Signal and trust for Ars Technica

This source works at a steady pace: 100% of recent stories land in the hot window, and 0% carry visible search signal.

Trusted

Reliability

92

Freshness

100

Sources in storyline

3

Related articles

More stories that share tags, source, or category context.

More from Ars Technica

Fresh reporting and follow-up coverage from the same newsroom.

Open source page